Location History:
- Cambridge, MA (US) (2018)
- Winchester, MA (US) (2017 - 2021)
Company Filing History:
Years Active: 2017-2021
Title: The Innovations of Manav Korpal: A Pioneer in Breast Cancer Therapeutics
Introduction
Manav Korpal is an influential inventor based in Winchester, MA, whose contributions to the field of medicine have significantly advanced the treatment options available for breast cancer. With a total of four patents to his name, Korpal's work focuses on groundbreaking combination therapies aimed at targeting complex breast cancer mechanisms.
Latest Patents
Korpal's latest patents include innovative therapeutic approaches. One of his notable inventions is a patent for combination therapies for the treatment of breast cancer. This combination therapy integrates an ER-alpha inhibitor and a CDK 4/6 inhibitor, enhancing the efficacy of treatment. Another important patent involves tetrasubstituted alkene compounds and their use in treating breast cancer. The compounds, or their pharmaceutically acceptable salts, are administered to patients in need of a therapeutically effective amount, specifically targeting ER-positive breast cancer as well as patients expressing a mutant ER-alpha protein.
Career Highlights
Throughout his career, Manav Korpal has demonstrated dedication to research and development in oncology. He has held significant roles at renowned companies such as Eisai R&D Management Co., Ltd. and Novartis AG. His work in these organizations has further honed his expertise in developing advanced cancer treatments.
Collaborations
In his research journey, Korpal has collaborated with esteemed professionals, including Peter G. Smith and Ping Zhu. These partnerships have facilitated the exchange of ideas and innovation, allowing for more comprehensive approaches to cancer treatment.
Conclusion
Manav Korpal stands out as a pioneering inventor in the field of cancer therapeutics. His innovative patents, commitment to research, and collaborative spirit have made significant strides in enhancing treatment options for breast cancer patients. As we move forward, Korpal's contributions will undoubtedly continue to shape the landscape of oncology research and patient care.